Anika Therapeutics Inc. Stock News

Anika Therapeutics (NASDAQ:ANIK) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, Zacks.com reports. The broke

Bank of America Corp DE reduced its holdings in shares of Anika Therapeutics Inc (NASDAQ:ANIK) by 42.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 9,211 shares of the biote

ANIK vs. ALKS: Which Stock Is the Better Value Option?

ANIK vs. ALKS: Which Stock Is the Better Value Option?

The "Global Wound Care Biologics Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Anika Therapeutics Inc:

Anika Therapeutics appoints Cheryl Blanchard, Ph.D. as CEO ANIK

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, t

Boston Trust Walden Corp lifted its position in shares of Anika Therapeutics Inc (NASDAQ:ANIK) by 48.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 326,319

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Merit Medical Systems (MMSI), with a price target of $42.00. The

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Merit Medical Systems (MMSI – Research

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first quarter 2020 financial results after the close of the market on Thursday, May 7, 2020 and hold its inv

Boston Trust Walden Corp boosted its holdings in Anika Therapeutics Inc (NASDAQ:ANIK) by 76.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 387,747 shar

Anika Therapeutics (NASDAQ:ANIK) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Tuesday, Zacks.com reports. The brokerage presently has

Anika Therapeutics (NASDAQ:ANIK) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Wednesday, BidAskClub reports.